CLASS II ONGOING Device recall · Reported 29 Jul 2026 · FDA Enforcement Report

SnapshotGLO Wound Imaging Device recalled by Kent Imaging

Kent Imaging is recalling SnapshotGLO Wound Imaging Device, distributed nationwide in the US. The recall was initiated on 30 Jun 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: B376KB1000, Software Revisions v4.2.0 and v4.1.3
Quantity recalled77

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2775-2026
FDA event ID
99406
Recalling firm
Kent Imaging, Calgary, N/A
Classification
Class II
Status
Ongoing
Recall initiated
30 Jun 2026
FDA classified
22 Jul 2026
Reported
29 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Device Malfunction

Timeline

30 Jun 2026Recall initiated by company
22 Jul 2026Classified by FDA+22 days
29 Jul 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable/ unavailable for wound imaging until corrected.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.

Where it was distributed

US Nationwide distribution in the states of PA, IA, FL, TX, GA, NV, CA, UT, IN, DC, KS, IL, TN, AR, AZ.

Nationwide ArkansasArizonaCaliforniaDistrict of ColumbiaFloridaGeorgiaIowaIllinoisIndianaKansasNevadaPennsylvaniaTennesseeTexasUtah

Questions about this recall

Why was it recalled?

The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable/ unavailable for wound imaging until corrected.

Which lots are affected?

UDI-DI: B376KB1000, Software Revisions v4.2.0 and v4.1.3

Where was it sold?

US Nationwide distribution in the states of PA, IA, FL, TX, GA, NV, CA, UT, IN, DC, KS, IL, TN, AR, AZ.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Kent Imaging

All 2
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IISnapshot NIR recalled by Kent ImagingKent ImagingOtherNationwide

Other Imaging Equipment recalls

All 2,349